Skip to content

Edgewise Therapeutics, Inc.

EWTX· NasdaqCore metricsCIK 1710072

Pharmaceutical preparations551 peers

Last sale
Oct 23, 2026 · -1.66%
Market cap
$4.30B
109.46M shares
Filings
425
—
—
—
$1.17B
Q3 2026N/M FY25 yoy
-$46.14M
Q3 2026N/M FY25 yoy
-$163.61M
Q3 2026derivedN/M FY25 yoy
$9.65
Q3 2026N/M FY25 yoy
$68.68M
Q3 2026+46.8% FY25 yoy
$4.30B
—
—
2.6×
-3.35%
—

FY2025 figures · derived

Price

$39.32+164.25%+$24.44past year
Oct 23, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$151.39MFY 2025
$151.39M0FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$151,389,000reported
FY 20242024-12-31$126,966,000reported
FY 20232023-12-31$90,905,000reported
FY 20222022-12-31$54,032,000reported
FY 20212021-12-31$32,189,000reported
FY 20202020-12-31$14,983,000reported

Pharmaceutical preparations

Edgewise Therapeutics, Inc. is the 57th largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Edgewise Therapeutics, Inc. · CIK 1710072 · Engraved from SEC EDGAR